Theme

Field-oriented
Sessions

Session Title

Drug delivery

PresentationNo.

AbstractNo.

Lecture title

DRU-IS-01

SPKR-40

Convection enhanced delivery (CED) in the brain stem of children with diffuse intrinsic
pontine glioma (DIPG): beyond feasibility

Mark Souweidane

USA

DRU-O-02

DDEL-11

Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse intrinsic
pontine glioma

Takahiro Sasaki

USA

DRU-O-03

DDEL-08

Convection-enhanced delivery of Nimustine Hydrochloride (ACNU) against pediatricdiffuse intrinsic pontine gliomas

Ryuta SaitoJapanDRU-O-04

DDEL-04

Engineered nanocarriers to enhance drug delivery across the blood-brain barrier

Joelle Straehla

USADRU-O-05

DDEL-15

Nanotherapeutic targeting of tumor endothelium for enhancing drug delivery past theblood-brain barrier

Praveen Raju

USADRU-P-06

DDEL-02

Decreased toxicity of conventional dose chemotherapy utilizing body weight instead ofbody surface area for dosing in young children <6 years old enrolled on the “Head Start” Girish Dhall
4 clinical trial

USADRU-P-07

DDEL-16

Understanding optimal convection-enhanced delivery physico-chemical infusion
parameters: The role of BBB efflux pumps in drug distribution and clearance

Erica PowerUSADRU-P-08

DDEL-07

A Phase I study examining the feasibility of intermittent convection-enhanced delivery(CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline
gliomasStergios Zacharoulis

USADRU-O-09

DIPG-82

Clinical experience of Convection Enhanced Delivery (CED) of Carboplatin and Sodium
Valproate into the pons for the treatment of Diffuse Intrinsic Pontine Glioma (DIPG) in Elwira Szychot
children and young adults after radiotherapy

UKDRU-P-10

DDEL-03

Long-term intraventricular therapy alternating etoposide and liposomal cytarabine:
Experience in 75 children and adolescents with malignant brain tumors

Natalia Stepien

Austria

DRU-P-11

DDEL-01

Enhancing drug delivery with MRgFUS for diffuse intrinsic pontine glioma model

Joji Ishida

CanadaDRU-P-12

DDEL-05

Blood-brain barrier disruption and enhanced radiosensitizers extravasation upon
focused ultrasound for treatment of diffuse intrinsic pontine glioma

Elvin t Hart

Netherlands

DRU-P-13

DDEL-09

High dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle
in a non-human primate model

Rachael Sirianni

USADRU-P-14

DDEL-13

Focused ultrasound mediated blood brain barrier disruption in a murine model ofpontine glioma: A safety and feasibility study

Zachary Englander

USA

DRU-P-15

DDEL-10

A nanoparticle platform for intrathecal delivery of the histone deacetylase inhibitor(HDACi) panobinostat in metastatic or recurrent medulloblastoma

Rachael Sirianni

USA

DRU-P-16

DDEL-14

Safety of Interventricular Methotrexate administration following radiation in pediatricpatients with malignant brain tumors

Ziad KhatibUSA

DRU-P-17

DDEL-06

Drug interaction between everolimus and cannabidiol in pediatric patients with
subependymal giant cell astrocytomas: A single institution experience

Ashley Sabus

USADRU-P-18

DDEL-12

Nanoparticle delivery of Doxorubicin for the treatment of Diffuse Intrinsic Pontine
Glioma (DIPG).

Caitlin Ung

Australia

DRU-P-19

DDEL-17

Triple intraventricular chemotherapy for treatment of relapsed choroid plexus carcinoma Grace Lau

Australia

SpeakerCountry